BeiGene, Ltd. (ONC) — Cash Flow-to-Debt Ratio
BeiGene, Ltd. (ONC) has a Cash Flow-to-Debt Ratio of 0.05x as of March 2026, meaning its operating cash flow of $201.94 Million could theoretically repay 0% of its total liabilities ($3.79 Billion) in one year. See BeiGene, Ltd. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
BeiGene, Ltd. Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for BeiGene, Ltd. across 13 annual periods. Also explore BeiGene, Ltd. (ONC) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for BeiGene, Ltd. (2013–2025)
Year-by-year debt coverage analysis for BeiGene, Ltd.. For market capitalisation and broader financial context, see ONC company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.29x | $1.13 Billion | $3.83 Billion | ▲ +642.3% |
| 2024 | -0.05x | $-140.63 Million | $2.59 Billion | ▲ +89.4% |
| 2023 | -0.51x | $-1.16 Billion | $2.27 Billion | ▲ +31.9% |
| 2022 | -0.75x | $-1.50 Billion | $2.00 Billion | ▼ -38.7% |
| 2021 | -0.54x | $-1.30 Billion | $2.40 Billion | ▲ +27.1% |
| 2020 | -0.74x | $-1.28 Billion | $1.73 Billion | ▲ +37.4% |
| 2019 | -1.18x | $-750.27 Million | $633.93 Million | ▼ -7.2% |
| 2018 | -1.10x | $-547.72 Million | $496.04 Million | ▼ -3236.7% |
| 2017 | 0.04x | $12.75 Million | $362.25 Million | ▲ +102.1% |
| 2016 | -1.69x | $-89.51 Million | $52.91 Million | ▼ -80.2% |
| 2015 | -0.94x | $-39.84 Million | $42.45 Million | ▼ -200.7% |
| 2014 | -0.31x | $-8.69 Million | $27.85 Million | ▼ -473.7% |
| 2013 | 0.08x | $4.07 Million | $48.76 Million | — |